Data as of Q4 2025 (Dec 31, 2025)
โณ
Showing Q2 2024 data
Abbrea Capital, LLC's Q4 2025 filing not yet available. Expected by Feb 14, 2026.

Abbrea Capital, LLC

โ€ขCIK: 1697646โ€ขFiling: Q2 2024

**Abbrea Capital, LLC** manages $755M across a diversified portfolio of 226 positions. The fund exhibits significant concentration in mega-cap technology and index exposure, with top holdings including MSFT ($45.5M), AAPL ($43.8M), and SPY ($36.5M). Notable allocations also include OEF ($32.8M) and NVDA ($27.8M), suggesting a strategic tilt toward established growth leaders and market beta plays. This positioning reflects a conviction in large-cap technology resilience and broad market participation.

Total AUM
$755.3M
QoQ Performance
-0.5%
Positions
226
Top 10 Concentration
38.8%
Latest Filing
Q2 2024

Top Holdings Allocation

MSFT
AAPL
MSFT6.0%
AAPL5.8%
SPY4.8%
OEF4.3%
NVDA3.7%
COST3.6%
META2.8%
AMZN2.6%

๐Ÿ“ˆ Biggest Buys

NVDA
Nvidia Corp
+785.0%
3.7% of portfolio
INDA
iShares MSCI India ETF
+133.9%
0.5% of portfolio
EMXC
iShares Emerging Markets exChina ETF
+55.9%
0.6% of portfolio
VEA
Vanguard FTSE Developed ETF
+11.5%
1.7% of portfolio
BND
Vanguard Total Bond
+8.6%
1.9% of portfolio

๐Ÿ“‰ Biggest Sells

AAPL
Apple Inc
-8.3%
5.8% of portfolio
AMZN
Amazon Com Inc
-9.7%
2.6% of portfolio
MSFT
Microsoft Corp
-4.0%
6.0% of portfolio
GOOGL
Alphabet Inc CL A
-7.2%
2.5% of portfolio
META
Meta Platforms, Inc
-5.8%
2.8% of portfolio

Sector Breakdown

Other38.3%
Technology27.2%
Consumer8.4%
ETF7.1%
Healthcare5.8%
Financial5.3%
Industrial3.5%
Consumer Staples1.7%

๐Ÿšช Exited Positionssold since Q1 2024

SCHE
Schwab Emerging Markets
SOLD
$1.5M
SCHB
Schwab US Broad Market ETF
SOLD
$584.0K
MRNA
Moderna Inc
SOLD
$507.0K
SPGI
S & P Global Inc
SOLD
$437.0K
DON
SPDR Dow Jones
SOLD
$435.0K
+42 more exited positions

Changes from Q1 2024

โ†‘35 increased
โ†“141 decreased

Historical Filings

Q2 2024Q1 2024Q4 2023